Summary
McKesson Corporation's (MCK) Q2 fiscal year 2016 report shows robust revenue growth, with a 10% increase year-over-year to $48.8 billion for the quarter and a 10% increase to $96.3 billion for the first six months. This growth was primarily driven by the Distribution Solutions segment, particularly North America pharmaceutical distribution and services, which saw a 16% revenue increase in the quarter. Net income attributable to McKesson Corporation rose significantly by 32% to $617 million for the quarter, resulting in diluted earnings per share of $2.63, up from $1.99 in the prior year. The company continues to expand its operations through strategic acquisitions, announcing agreements to acquire the pharmaceutical distribution business of UDG Healthcare Plc and the pharmacy business of J Sainsbury Plc. These moves are expected to bolster its International pharmaceutical distribution and services within the Distribution Solutions segment. Despite these strategic investments and a challenging pricing environment due to generic drug conversions, McKesson demonstrated strong operational performance and increased profitability, positioning it favorably for continued growth.
Financial Highlights
53 data points| Revenue | $48.76B |
| Cost of Revenue | $45.92B |
| Gross Profit | $2.84B |
| Operating Expenses | $1.89B |
| Operating Income | $954.00M |
| Net Income | $617.00M |
| EPS (Basic) | $2.66 |
| EPS (Diluted) | $2.63 |
| Shares Outstanding (Basic) | 232.00M |
| Shares Outstanding (Diluted) | 235.00M |
Key Highlights
- 1Total revenues increased by 10% to $48.8 billion for the quarter ended September 30, 2015, and by 10% to $96.3 billion for the six months ended September 30, 2015, driven by the Distribution Solutions segment.
- 2Net income attributable to McKesson Corporation saw a substantial increase of 32% to $617 million for the quarter, with diluted earnings per share rising to $2.63 from $1.99 in the prior year period.
- 3Operating income from continuing operations grew by 23% to $880 million for the quarter, reflecting improved operational performance.
- 4McKesson announced agreements to acquire UDG Healthcare Plc's pharmaceutical distribution business for approximately $457 million and J Sainsbury Plc's UK pharmacy business for approximately $190 million, signaling strategic international expansion.
- 5The company repurchased $605 million of its common stock during the first six months of the fiscal year, demonstrating a commitment to returning capital to shareholders, and subsequently authorized an additional $2 billion repurchase program.
- 6Despite a decrease in gross profit margin within the Distribution Solutions segment due to pricing pressures and product mix, the overall segment operating profit margin increased, showcasing effective cost management.
- 7The company maintained a strong financial position with cash and cash equivalents of $5.4 billion and a debt-to-capital ratio of 51.7% as of September 30, 2015.